Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. - Wikidata - awgldk - TriplyDB

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival.

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival.

http://www.wikidata.org/entity/Q42436373

about

Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach Current stage in inflammatory bowel disease: What is next?Shining a light on intestinal traffic CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis.Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse Delayed resolution of acute inflammation in ulcerative colitis is associated with elevated cytokine release downstream of TLR4.Dietary phenethylisothiocyanate attenuates bowel inflammation in mice.Pien Tze Huang Gan Bao ameliorates carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats.NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse.Increased intestinal epithelial cell turnover and intestinal motility in Gymnophalloides seoi-infected C57BL/6 mice.Protective effect of recombinant human IL-1Ra on CCl4-induced acute liver injury in mice.Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study.Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl- secretion.CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression.Protective effects of total glucosides of paeony and the underlying mechanisms in carbon tetrachloride-induced experimental liver injury Differential alterations in the small intestine epithelial cell turnover during acute and chronic infection with Echinostoma caproni (Trematoda)Curcumin inhibits interferon-γ signaling in colonic epithelial cells.Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen.CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats Chemokine and cytokine levels in inflammatory bowel disease patients.Mechanisms of acupuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis.Leukocyte Trafficking to the Small Intestine and Colon CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia?CXCL10 blockade protects mice from cyclophosphamide-induced cystitis Qingchang Wenzhong Decoction Ameliorates Dextran Sulphate Sodium-Induced Ulcerative Colitis in Rats by Downregulating the IP10/CXCR3 Axis-Mediated Inflammatory Response.Trichuris muris research revisited: a journey through time Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis Airway smooth muscle chemokine receptor expression and function in asthma Aqueous extract of Gracilaria tenuistipitata suppresses LPS-induced NF-κB and MAPK activation in RAW 264.7 and rat peritoneal macrophages and exerts hepatoprotective effects on carbon tetrachloride-treated rat.Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study.Intestinal CCL11 and eosinophilic inflammation is regulated by myeloid cell-specific RelA/p65 in mice.Targeting T-cell migration in inflammatory bowel disease.Lactocepin as a protective microbial structure in the context of IBD.Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study.Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases.NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines.Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase.

P2860

Q24594741-1E25F86C-003C-411F-9342-5F52C6BE7C2B Q26777429-05A048B5-316E-4C6A-A052-C1711F937419 Q26863227-2B07C8E3-27F3-4054-9676-B7DA3C21E8E9 Q33340680-C30D5548-4E74-43AD-9016-0975AFC43539 Q33527394-242BF000-21DD-4ED6-A197-9CEFBDD5AF92 Q33548741-6B0401BF-B79F-440D-B8E8-A7C652A03FF6 Q33566354-E2D1FCC2-5875-4E2C-B9FC-6BC06C56C743 Q33723975-F2E8FE53-72FB-4F51-AC55-4EA75C82BE59 Q33782590-557E19B5-BC41-4DCE-B98B-34D6C9A606A0 Q33892454-7E7CA5F4-9D73-42EC-9257-52E3970EC99A Q33896170-A0D1D922-CEB0-4EC0-8FC9-06BF1CE90BB6 Q33903615-78F0D6AC-E7B6-463F-BBA8-1074FBC83A27 Q34507117-79D429EA-8370-4859-BAF7-1A4B039BFD29 Q34787194-C1E02852-6A5B-4217-8F3E-EF4439568EAA Q35083458-AB0D9FCF-CCF4-4B8E-A07C-60A4BB47DE02 Q35609379-9D549F0B-72B4-40C0-ABB7-16EEA582FDD8 Q35674251-E7101BB9-BC5F-4213-9420-5EC8336F9741 Q35786415-DA02C4E6-9807-4615-B34E-B62B93CF2D0F Q35939370-144843C9-258E-43CD-B311-724D5B75462D Q36075877-45AA591C-4CE8-48FA-ACE9-78A953F24F6D Q36166383-2BFEE526-BAA3-441A-B6DC-05A93E0D65FA Q36238175-6FAFE8C9-8264-4F71-881F-5FC9EC7BA6B1 Q36338594-934F390D-C893-468F-BF33-555AB9DB32DC Q36474134-617B6115-B625-4995-80A9-41B5031CD00C Q36592984-60F9B5AC-62CC-448E-B2D6-B87531B52F77 Q36676660-8EA94ED8-1BFB-4D69-9EE7-FD9767702CCF Q36975105-9202C339-123B-4135-8CC1-6F137D1D584A Q37054120-5E2BA732-F1F6-4387-81FA-D9BC7D579679 Q37142724-F7EF15F2-66CB-4EBB-9354-E1D429CC15D0 Q37308981-1D0EAD9E-9AE6-48BD-BD51-E0EFFECA2F9F Q37414555-F09F9494-4E99-4133-BE48-4D525925C863 Q37520860-A1539B91-F437-429B-ABB0-E008468C9DB9 Q37600224-DAED0EEB-0AA8-45DE-8E60-80238C7E83AC Q37672482-B36FE21D-E841-4B0D-B584-F32875646239 Q38040430-AA6C7CF6-F9E7-4BEB-B26A-D7D6E8FA6CE8 Q38075379-99A1507F-EA0B-4956-99CE-9482B78D38FB Q38379118-DAAABE54-1B9F-40AB-95FC-D7431ABA8627 Q38744708-E9CFE824-00C4-418B-B73B-A4AD0E4F7159 Q40043011-C700A832-60ED-4305-ADED-D39C4ADA26DA Q40791151-732CE116-3DB8-4DE7-9AA0-BA3A0C5C41DC

P2860

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival.

http://www.wikidata.org/entity/Q42436373

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival.

@en

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival.

@nl

type

label

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival.

@en

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival.

@nl

prefLabel

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival.

@en

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival.

@nl

P1433

Q42436373-AA05635E-58EF-4ED3-B0A9-528AE15A24EE

P1476

Q42436373-6AE5F8CE-0240-4705-8A2A-4BD0781E97EC

P2093

Q42436373-164483EC-D4A8-4508-BFA9-4729A44AE7F2

Q42436373-2B45F189-838D-4696-8E6F-7AC7B9218A41

Q42436373-4136024E-1B7A-4788-A7D7-F28D041B83C3

Q42436373-79811C47-6511-404B-A10B-4691CFE1CF40

Q42436373-7AE65703-E9D7-4C23-AFC2-39F4F7729B4E

Q42436373-8B865A4C-E549-4014-B036-602032EBFAE6

Q42436373-8D9337A5-1B64-4E22-B889-7466CAD69AAE

Q42436373-A2029763-34C0-4091-B3A7-448A58D96EC6

Q42436373-C535BDD1-988C-430A-9532-3FB80C5C3B18

Q42436373-E2BE7AE1-1BAC-480C-BDAC-D914369EB46B

P304

Q42436373-B8864762-F064-4EA8-9276-927644F0D86F

P31

Q42436373-9F4DE28A-7CAB-4555-A59E-05235C278210

P356

Q42436373-D85CDB9A-8FBF-4D06-BDDD-039EF863CED0

P407

Q42436373-A7C5DAEE-8935-4668-BCE0-4E84E1005CEC

P433

Q42436373-AFCDE29A-A8C3-4CA6-904F-2E861BCAAD92

P478

Q42436373-73F993AA-A2B4-4DEF-9951-6ACA29F48DA9

P577

Q42436373-957031A3-3F69-42D3-8113-DF629F20572E

P698

Q42436373-B1FE0A6B-C06D-4D0B-8B8A-7FAA59F088C2

P356

1521-4141(200211)32:11%3C3197::AID-IMMU3197%3E3.0.CO;2-1

P1433

European Journal of Immunology

P1476

Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival.

@en

P2093

Fujio Shimizu

http://www.w3.org/2001/XMLSchema#string

Hidehisa Suriki

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kawachi

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Yoneyama

http://www.w3.org/2001/XMLSchema#string

Hitoshi Asakura

http://www.w3.org/2001/XMLSchema#string

Kenji Suzuki

http://www.w3.org/2001/XMLSchema#string

Kouji Matsushima

http://www.w3.org/2001/XMLSchema#string

Shiro Watanabe

http://www.w3.org/2001/XMLSchema#string

Shosaku Narumi

http://www.w3.org/2001/XMLSchema#string

Shunya Sasaki

http://www.w3.org/2001/XMLSchema#string

P304

3197-3205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12555665

http://www.w3.org/2001/XMLSchema#string